Sinus stent safety confirmed in 215-Patient european study

NCT ID NCT05925985

First seen Jan 20, 2026 · Last updated May 15, 2026 · Updated 23 times

Summary

This study followed 215 adults with chronic rhinosinusitis who received a corticosteroid-releasing sinus implant during sinus surgery. Researchers tracked symptom scores and endoscopic healing for up to 12 months to confirm the device's long-term safety and performance. The goal was to ensure the implant works as intended and to identify any new risks.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC RHINOSINUSITIS (DIAGNOSIS) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • HNO Praxis & Rhinologie Zentrum München

    München, Germany

  • Helios Dr Horst Schmidt Kliniken

    Wiesbaden, Germany

  • Imperial College Healthcare NHS Trust - Charing Cross Hospital

    London, United Kingdom

  • Katholisches Krankenhaus Hagen

    Hagen, Germany

  • Saint Elisabeth Krankenhaus Köln-Hohenlind

    Cologne, Germany

  • Städtisches Klinikum Karlsruhe GmbH

    Karlsruhe, Germany

  • Universitätsklinikum Freiburg Klinik für Hals, Nasen und Ohrenheilkunde

    Freiburg im Breisgau, Germany

  • Universitätsklinikum Münster Klinik für Hals, Nasen und Ohrenheilkunde

    Münster, Germany

  • Universitätsklinikum Schleswig-Holstein Campus Lübeck

    Lübeck, Germany

Conditions

Explore the condition pages connected to this study.